Loading...

Carol M Richman

Title(s)Professor Emeritus, Hematology and Oncology
SchoolUniversity of California, Davis
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M. Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis. Br J Haematol. 2018 09; 182(6):916-920. PMID: 28771676.
      View in: PubMed
    2. Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant. 2013 Aug; 19(8):1238-43. PMID: 23751955.
      View in: PubMed
    3. Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ. Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1192-8. PMID: 16965873.
      View in: PubMed
    4. DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL. Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7187s-7194s. PMID: 16203820.
      View in: PubMed
    5. Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7158s-7163s. PMID: 16203816.
      View in: PubMed
    6. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. PMID: 16115934.
      View in: PubMed
    7. Shen S, DeNardo SJ, Richman CM, Yuan A, Siantar CH, O'Donnell RT, Kroger LA, DeNardo GL. Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. J Nucl Med. 2005 Jun; 46(6):1034-41. PMID: 15937317.
      View in: PubMed
    8. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. PMID: 15530258.
      View in: PubMed
    9. Wang H, Laslett LJ, Richman CM, Wun T. Acute myocardial infarction in hemoglobin SC disease. Ann Hematol. 2004 Oct; 83(10):622-4. PMID: 15300406.
      View in: PubMed
    10. Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C. Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature. Am J Hematol. 2004 Apr; 75(4):231-8. PMID: 15054816.
      View in: PubMed
    11. DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3938S-44S. PMID: 14506192.
      View in: PubMed
    12. DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C, DeNardo S. Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs. Cancer Biother Radiopharm. 2003 Apr; 18(2):231-7. PMID: 12804049.
      View in: PubMed
    13. Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, Holland PV, Richman C, Paglieroni TG, Wun T. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion. 2002 Dec; 42(12):1567-72. PMID: 12473136.
      View in: PubMed
    14. Law L, Tuscano J, Wun T, Ahlberg K, Richman C. Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia. Int J Hematol. 2002 Nov; 76(4):360-4. PMID: 12463601.
      View in: PubMed
    15. Wang SE, Lara PN, Lee-Ow A, Reed J, Wang LR, Palmer P, Tuscano JM, Richman CM, Beckett L, Wun T. Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol. 2002 Jul; 70(3):191-4. PMID: 12111764.
      View in: PubMed
    16. Martel L, Reddy K, Greco M, Tuscano M, Richman M, Wun T. Isolated cavernous sinus extramedullary relapse of chronic myelogenous leukemia following allogeneic stem cell transplant. Ann Hematol. 2002 Feb; 81(2):108-10. PMID: 11907793.
      View in: PubMed
    17. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. PMID: 11410491.
      View in: PubMed
    18. Richman CM, DeNardo SJ. Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies. Crit Rev Oncol Hematol. 2001 Apr; 38(1):25-35. PMID: 11255079.
      View in: PubMed
    19. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. PMID: 11251003.
      View in: PubMed
    20. DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ. Strategies for developing effective radioimmunotherapy for solid tumors. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3219s-3223s. PMID: 10541367.
      View in: PubMed
    21. Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3243s-3248s. PMID: 10541370.
      View in: PubMed
    22. Denardo SJ, Richman CM, Kukis DL, Shen S, Lamborn KR, Miers LA, Kroger LA, Perez EA, Denardo GL. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Res. 1998 Nov-Dec; 18(6A):4011-8. PMID: 9891439.
      View in: PubMed
    23. DeNardo GL, Kroger LA, Meares CF, Richman CM, Salako Q, Shen S, Lamborn KR, Peterson JJ, Miers LA, Zhong GR, DeNardo SJ. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clin Cancer Res. 1998 Oct; 4(10):2483-90. PMID: 9796981.
      View in: PubMed
    24. DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2583-90. PMID: 9406713.
      View in: PubMed
    25. Richman CM, Schuermann TC, Wun T, Malik R, O'Donnell RT, DeNardo GL, DeNardo SJ. Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2728-32. PMID: 9406731.
      View in: PubMed
    26. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med. 1997 Aug; 38(8):1180-5. PMID: 9255145.
      View in: PubMed
    27. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. PMID: 9179227.
      View in: PubMed
    28. Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody. Anticancer Res. 1997 May-Jun; 17(3B):1745-51. PMID: 9179228.
      View in: PubMed
    29. Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 1995 Dec 01; 55(23 Suppl):5916s-5920s. PMID: 7493370.
      View in: PubMed
    30. Ghalie R, Richman CM, Adler SS, Cobleigh MA, Korenblit AD, Manson SD, McLeod BC, Taylor SG, Valentino LA, Wolter J. Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. J Clin Oncol. 1994 Feb; 12(2):342-6. PMID: 8113841.
      View in: PubMed
    31. Ghalie R, Richman CM, Bender JG, McLeod BC, Lee W, Czyzewski A, Manson S, Cobleigh MA, Reed S, Pierre R. Sequential transplants using mobilized peripheral blood progenitor cells. J Clin Apher. 1994; 9(3):176-82. PMID: 7535760.
      View in: PubMed
    32. DeNardo SJ, O'Grady LF, Richman CM, DeNardo GL. Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6. Adv Exp Med Biol. 1994; 353:203-11. PMID: 7527179.
      View in: PubMed
    33. Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H. Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol. 1993 Apr; 42(4):350-3. PMID: 8493984.
      View in: PubMed
    34. DeNardo SJ, DeNardo GL, Richman CM. Enhancement of clinical radioimmunotherapy for cancer and the role of cytokines. J Natl Cancer Inst. 1992 Mar 18; 84(6):374-5. PMID: 1538409.
      View in: PubMed
    35. Ghalie R, McLeod B, Richman C, Valentino L, Manson S, Netols C, Kaizer H. Peripheral blood stem cell transplantation: impact on procedure load and workload in an apheresis unit. J Clin Apher. 1992; 7(4):201-7. PMID: 1363730.
      View in: PubMed
    36. Ghalie R, Richman CM, Adler SS, Korenblit AD, Kramer TS, Manson S, Dolce A, Kaizer H. Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas. Bone Marrow Transplant. 1991 Jul; 8(1):41-5. PMID: 1912954.
      View in: PubMed
    37. Richman CM, Slapak CA, Toh B. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity. J Biol Response Mod. 1990 Dec; 9(6):570-5. PMID: 1705960.
      View in: PubMed
    38. Murphy PB, Richman CM. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia. Exp Hematol. 1989 Dec; 17(11):1105-9. PMID: 2583254.
      View in: PubMed
    39. Richman CM, Johnson GD. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E1. Blood. 1987 Dec; 70(6):1792-6. PMID: 3499944.
      View in: PubMed
    40. Richman CM, Podczaski E, Weiser PA, Herbst AL. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7. PMID: 3079898.
      View in: PubMed
    41. Slapak CA, Fine RL, Richman CM. Differential protection of normal and malignant human myeloid progenitors (CFU-GM) from Ara-C toxicity using cycloheximide. Blood. 1985 Oct; 66(4):830-4. PMID: 3862435.
      View in: PubMed
    42. Richman CM, Holt JA, Lorincz MA, Herbst AL. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet Gynecol. 1985 Feb; 65(2):257-63. PMID: 3969239.
      View in: PubMed
    43. Preisler HD, Raza A, Higby D, Kirshner J, Woll J, Bennett J, Winton L, Weiner R, Richman C, Golomb H. Treatment of myeloid blastic crisis of chronic myelogenous leukemia. Cancer Treat Rep. 1984 Nov; 68(11):1351-5. PMID: 6388833.
      View in: PubMed
    44. Richman CM, Makii MM, Weiser PA, Herbst AL. The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23. PMID: 6426295.
      View in: PubMed
    45. Richman CM. Prolonged cryopreservation of human granulocytes. Transfusion. 1983 Nov-Dec; 23(6):508-11. PMID: 6649027.
      View in: PubMed
    46. Hoffman PC, Richman CM, Larson RA, Yachnin S. Cholesterol and mevalonic acid are independent requirements for the in vitro proliferation of human bone marrow granulocyte progenitor cells: studies using ML-236B. Blood. 1983 Apr; 61(4):667-71. PMID: 6831033.
      View in: PubMed
    47. Richman CM, Rowley JD. Correlation of in vitro culture pattern and Q-banded karyotype in acute nonlymphocytic leukemia. Am J Hematol. 1983 Feb; 14(1):37-47. PMID: 6837567.
      View in: PubMed
    48. Parker LM, Binder N, Gelman R, Richman CM, Weiner RS, Yankee RA. Prolonged cryopreservation of human bone marrow. Transplantation. 1981 Jun; 31(6):454-7. PMID: 7256827.
      View in: PubMed
    49. Richman CM, Kinnealey A, Hoffman PC. Granulopoietic effects of lithium on human bone marrow in vitro. Exp Hematol. 1981 Apr; 9(4):449-55. PMID: 6972319.
      View in: PubMed
    50. Hoffman PC, Richman CM, Hsu RC, Chung J, Scanu AM, Yachnin S. Effect of oxygenated sterol compounds on human bone marrow granulocytic progenitor cells. Blood. 1981 Jan; 57(1):164-9. PMID: 7448408.
      View in: PubMed
    51. Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15; 46(4):669-74. PMID: 7397632.
      View in: PubMed
    52. Rich KC, Richman CM, Mejias E, Daddona P. Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency. J Clin Invest. 1980 Aug; 66(2):389-95. PMID: 7400322.
      View in: PubMed
    53. Roth DG, Richman CM, Rowley JD. Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. Blood. 1980 Aug; 56(2):262-4. PMID: 6930980.
      View in: PubMed
    54. Richman CM, Golomb HM. Hairy cell leukemia: effect of 'hairy' cells on normal granulopoiesis in vitro. Exp Hematol. 1979 Sep; 7(8):411-5. PMID: 315881.
      View in: PubMed
    55. Weiner RS, Richman CM, Yankee RA. Dilution techniques for optimum recovery of cryopreserved bone marrow cells. Exp Hematol. 1979; 7 Suppl 5:1-6. PMID: 263236.
      View in: PubMed
    56. Weiner RS, Richman CM, Yankee RA, Parker L. Clinical results of autotransplantation after nitrosourea therapy. Exp Hematol. 1979; 7 Suppl 5:384-8. PMID: 400701.
      View in: PubMed
    57. Richman CM, Chess L, Yankee RA. Purification and characterization of granulocytic progenitor cells (CFU-C) from human peripheral blood using immunologic surface markers. Blood. 1978 Jan; 51(1):1-8. PMID: 338057.
      View in: PubMed
    58. Tobias JS, Weiner RS, Giffiths CT, Richman CM, Parker LM, Yankee RA. Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. Eur J Cancer. 1977 Mar 29; 13(3):269-77. PMID: 324770.
      View in: PubMed
    59. Weiner RS, Richman CM, Yankee RA. Semicontinuous flow centrifugation for the pheresis of immunocompetent cells and stem cells. Blood. 1977 Mar; 49(3):391-7. PMID: 138455.
      View in: PubMed
    60. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood. 1976 Jun; 47(6):1031-9. PMID: 1276467.
      View in: PubMed